Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

Categories for... News

News

Freak chemistry accident turns Sygnature’s Senior VP – Alliance Management into legendary werewolf

READ ARTICLE

DMPK in vivo pharmacology News

Three of UK’s top drug discovery CROs join forces under the name Sygnature Discovery

READ ARTICLE

Drug Discovery News

Sygnature Creates Second Integrated Drug Discovery Site at Alderley Park

READ ARTICLE

Blog Events News

Sygnature & Altasciences join forces for new webinar series

READ ARTICLE

Awards News

Sygnature Discovery named Company of the Year at Bionow Annual Awards

READ ARTICLE

Computational Sciences Drug Discovery News

Sygnature Discovery Adopts OpenEye’s Orion™ Platform to Strengthen Molecular Design Services

READ ARTICLE

Awards News

Sygnature Discovery shortlisted for BioNow Company of the Year Award

READ ARTICLE

Bioscience News

Sygnature upgrades western blotting capability with Jess instrument from Protein Simple

READ ARTICLE

News

Dr Paul Overton becomes Chief Commercial Officer (CCO) at Sygnature

READ ARTICLE

Bioscience News Translational Sciences

£3M investment to expand high-throughput screening and translational oncology capabilities

READ ARTICLE

News

What happened? A 2020 Recap!

READ ARTICLE

Awards News

Sygnature Discovery wins Medilink Outstanding Achievement Award

READ ARTICLE